Research
Read how they describe their research on their University of Toronto profile.
Latest funding
- $135,000
Humoral and cellular immunity to measles and varicella in immunocompromised children
CIHR · 2023 · Supervisor
- $784,125
Investigating the role of TNFR family signalling in T cell activation and memory formation during Type I interferon-dependent therapy of melanoma in mice
CIHR · 2023 · Nominated PI
- $105,000
Investigating the Impact of Tumor Necrosis Factor Inhibitors on SARS-CoV-2 mRNA Vaccine-induced Immunity in Immunocompromised Patients with Immune-mediated Inflammatory Diseases
CIHR · 2022 · Supervisor
No publications available.
Humoral and cellular immunity to measles and varicella in immunocompromised children
Principal investigators: Shapiro, Janna
Keywords: Acute Lymphoblastic; Antibodies; Autoimmunity; Immunocompromised; Juvenile Idiopathic Arthritis; Measles; Paediatric; T Cells; Vaccines,; Varicella
Investigating the role of TNFR family signalling in T cell activation and memory formation during Type I interferon-dependent therapy of melanoma in mice
Principal investigators: Watts, Tania H
Keywords: Cancer; Cgas-Sting; Genetic Models; Inflammatory Monocytes; Melanoma; Tissue Resident Memory T Cells; Tnfsf18 (Gitrl); Tnfsf9 (4-1bbl); Type I Interferon; Yumm Mouse Melanoma Model
Investigating the Impact of Tumor Necrosis Factor Inhibitors on SARS-CoV-2 mRNA Vaccine-induced Immunity in Immunocompromised Patients with Immune-mediated Inflammatory Diseases
Principal investigators: Cheung, Michelle W
Keywords: Adaptive Immunity; Bnt162b2 Sars-Cov-2 Vaccine; Cite-Sequencing; Covid-19; Immune-Mediated Inflammatory Diseases; Immunocompromised Patients; Mrna-1273 Sars-Cov-2 Vaccine; Severe Acute Respiratory Syndrome Coronavirus 2; Tumor Necrosis Factor Inhibitors
Monocyte derived cells and TNF family ligands in STING agonist therapy of cancer
Principal investigators: Watts, Tania H
Keywords: Adu S100; Cancer; Cgas-Sting; Genetic Models; Inflammatory Monocytes; Melanoma; T Cells; Tissue Resident Memory T Cells (Trm); Tnfrsf9 (4-1bb); Tnfsf18 (Gitr)
COVID-19 Variant Network - Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2
Principal investigators: Watts, Tania H; Ehrhardt, Rudolf A; Gommerman, Jennifer L; Martin, Alberto; Ostrowski, Mario A
Keywords: Antibody Dependent Enhancement; B Cell Reperotire; Correlates Of Protection; Covid19; Immune Memory; Neutralizing Antibody; Rna-Seq; Saliva Iga; T Cell Epitopes; Vaccines
Immune response after COVID-19 vaccination during maintenance therapy in immune-mediated inflammatory diseases: an observational cohort study (IMPACT)
Principal investigators: Chandran, Vinod
Keywords: Antibody Response; Covid-19; Immune-Mediated Inflammatory Diseases; Immunosuppression; T Cell Response; Vaccination; Variants Of Concern
Characterizing signal 4 for CD8 T cell accumulation and memory formation during respiratory influenza virus infection
Principal investigators: Watts, Tania H
Keywords: Antigen Presenting Cells; Cd8 T Cells; Cell Specific Gene Targeting; Cite Seq; Influenza Virus; Lung; Radiation Chimeras (Mixed Bone Marrow Chimeras); T Cell Memory; Tissue Resident Memory T Cells; Tnfr Superfamily 9 And 18 (4-1bb And Gitr)
COVID-19 Variant Supplement - Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2
Principal investigators: Watts, Tania H; Ehrhardt, Rudolf A; Gommerman, Jennifer L; Martin, Alberto; Ostrowski, Mario A
Keywords: Antibody Dependent Enhancement; B Cell Reperotire; Correlates Of Protection; Covid19; Immune Memory; Neutralizing Antibody; Rna-Seq; Saliva Iga; T Cell Epitopes; Vaccines
Canada Research Chair Tier 1
Principal investigators: Watts, Tania H
Keywords: Crc
Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2
Principal investigators: Watts, Tania H; Ehrhardt, Rudolf A; Gommerman, Jennifer L; Martin, Alberto; Ostrowski, Mario A
Keywords: Antibody Dependent Enhancement; B Cell Reperotire; Correlates Of Protection; Covid19; Immune Memory; Neutralizing Antibody; Rna-Seq; Saliva Iga; T Cell Epitopes; Vaccines
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.